Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Acylation. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel Friedel-Crafts route for Canagliflozin intermediate. High purity, scalable process reducing raw material complexity for global supply chains.
Novel copper-catalyzed decarboxylative acylation method offers mild conditions and high yields for reliable pharmaceutical intermediate supply chains.
Patent CN110577482B reveals a novel 2-step one-pot synthesis for Amisulpride. Discover cost-effective manufacturing, high purity yields, and reliable supply chain solutions.
Patent CN106029620B details a cost-effective Grignard route for 2-trifluoromethyl aromatic ketones, offering supply chain stability and high purity for pharmaceutical intermediates.
Advanced synthesis of arylamine nitrogen mustard derivatives via patent CN106631857A. Offers reduced toxicity and enhanced therapeutic index for pharmaceutical manufacturing.
Advanced catalytic hydrogenation and active anhydride acylation route for high-purity Tofacitinib Citrate, offering significant cost reduction and scalable manufacturing solutions.
Patent CN104356146A reveals one-pot synthesis for cefotiam hydrochloride. Enhances purity and yield while reducing manufacturing costs for reliable supply chains.
Patent CN108689815B details a novel copper-catalyzed method for indanone synthesis, offering significant cost reduction and green chemistry advantages for pharmaceutical manufacturing.
Patent CN102070596A details a high-yield dihydrosafrole synthesis via Friedel-Crafts acylation and Wolff-Kishner reduction, offering significant cost reduction in fine chemical intermediates manufacturing.
Novel patent CN102690224A details a cost-effective route for 3-(4-chlorobutyl)-1H-5-cyanoindole, replacing pyrophoric catalysts with stable reagents for scalable API production.
Advanced synthesis of Pemetrexed disodium intermediate via amino protection. Reduces impurities, lowers costs in API manufacturing, and ensures high-purity supply.
Patent CN103030647A details a scalable 6-step route for glabridin, eliminating cryogenic conditions and chromatography for significant cost reduction in cosmetic active manufacturing.
Novel C3-symmetric triptycene trimers enabling efficient singlet fission for next-gen solar cells and OLEDs. Scalable synthesis via Friedel-Crafts acylation.
Novel synthetic route for 5-chloro-1-indanone using 3-chlorobenzaldehyde. Reduces environmental pollution and simplifies scale-up for agrochemical intermediate manufacturing.
Novel Grignard-based process for halofuginone intermediate offering superior yield and scalable production for veterinary pharmaceutical supply chains.
Patent CN102382053B details a novel route for tolvaptan intermediate offering higher yield and purity for reliable pharmaceutical intermediates supplier operations.
Patent CN113185478A reveals a novel ethylenediamine-based route for N-Boc-piperazine, offering superior purity and cost reduction in pharmaceutical intermediate manufacturing.
Patent CN107879911A reveals aqueous silver-catalyzed synthesis. Reduces cost and environmental impact for pharmaceutical intermediate manufacturing supply chains globally.
Novel route for Iopamidol production via acylated intermediate. High purity, reduced impurities, and cost-effective manufacturing for global supply chains.
Patent CN86100852A discloses low-toxicity cephalosporin derivatives with superior antibacterial activity, offering reliable supply chain solutions for antibiotic manufacturing.